Screener
Pfizer PFE Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Pfizer’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000078003-26-000054
FAQ
- What is Pfizer's long-term debt?
- Pfizer (PFE) reported long-term debt of $60.57B in Q1 2026.
- How has Pfizer's long-term debt changed year-over-year?
- Pfizer's long-term debt increased by 5.1% year-over-year, from $57.64B to $60.57B.
- What is the long-term trend for Pfizer's long-term debt?
- Over 5 years (2020 to 2025), Pfizer's long-term debt has grown at a 10.7% compound annual growth rate (CAGR), from $37.13B to $61.64B.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Pfizer's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude